Neovacs S.A. announced earnings results for the half year ended June 30, 2018. For the period, the company's revenue was €19,000 against €512,000 a year ago. Operating loss was €6,621,000 against €10,244,000 a year ago. Operating income before tax was €7,203,000 against €10,280,000 a year ago. Net loss was €6,096,000 against €8,125,000 a year ago.